Does Rallies show live market data for NEO?

Rallies combines live market context with ticker research for NEO, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.

NEO (NeoGenomics, Inc.) Stock Analysis

NeoGenomics, Inc. (NEO) is a publicly traded Healthcare sector company. As of May 21, 2026, NEO trades at $8.95 with a market cap of $1.09B and a P/E ratio of 0.00. NEO moved +6.08% today. Year to date, NEO is -26.32%; over the trailing twelve months it is +11.39%. Its 52-week range spans $4.72 to $19.12. Analyst consensus is buy with an average price target of $14.94. Rallies surfaces NEO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest NEO stock research?

NeoGenomics, Inc. (NEO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NEO moved +6.08% today. Analyst consensus is buy.

NEO Key Metrics

Key financial metrics for NEO
Metric	Value
Price	$8.95
Market Cap	$1.09B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$19.12
52-Week Low	$4.72
Volume	775
Avg Volume	0
Revenue (TTM)	$727.33M
Net Income	$-108.03M
Gross Margin	43.21%

Latest NEO News

NeoGenomics Debuts RaDaR ST Assay for Residual Disease in Breast, Lung, Colorectal Tumors — Feb 25, 2026
NeoGenomics Down 22.8%, RSI 26.14 Signals Oversold, EPS Estimates Up 14.8% — Feb 20, 2026
NeoGenomics Reports 10% Revenue Growth to $727M Despite -$0.84 FY EPS — Feb 17, 2026
NeoGenomics Unveils PanTracer Pro with 500-Gene Profiling and 8-10 Day Turnaround — Feb 16, 2026
NeoGenomics Q3 Revenue Jumps 11.9% to $187.8M, Q4 Revenue Forecast at $188.3M — Feb 16, 2026

Recent NEO Insider Trades

Stone Warren sold 22.13K (~$276.68K) on Jan 20, 2026.
Olivo Alicia C sold 20.92K (~$250.99K) on Nov 25, 2025.
Olivo Alicia C sold 4.92K (~$49.18K) on Oct 16, 2025.

NEO Analyst Consensus

11 analysts cover NEO: 0 strong buy, 8 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.94.

Common questions about NEO

What can I research for NEO on Rallies?: NeoGenomics, Inc. (NEO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NEO moved +6.08% today. Analyst consensus is buy.
Does Rallies show live market data for NEO?: Rallies combines live market context with ticker research for NEO, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.